Left: Sid O’Bryant, PhD, Scientific Founder and Advisory Board Chair at CxPM; Right: CxPM CEO Danguole Altman [Photos: CxPM]
"I embarked on this journey of creating a blood test for Alzheimer’s detection in primary care because of my own clinical and personal experiences," said UNT HSC's Dr. Sid O’Bryant, founder of Cx Precision Medicine. Now, by joining the Moonshot community, CxPM has gained "invaluable access to a network of investors, collaborators, and strategic partners" that could help drive its mission forward.